Howard Fishman
Low Vision Rehabilitation · New Hyde Park, NYNPI 1124156559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.
Across 36 payments — averaging $82.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$332
- Biotissue Holdings Inc.$321
- Amgen$317
- Bausch & Lomb Americas Inc.$255
- Tarsus Pharmaceuticals, Inc.$232
- AbbVie$215
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,967100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 3 | $332 |
| Biotissue Holdings Inc. | 4 | $321 |
| Amgen(2 entities) | 3 | $317 |
| Bausch & Lomb Americas Inc. | 3 | $255 |
| Tarsus Pharmaceuticals, Inc. | 2 | $232 |
| AbbVie(2 entities) | 3 | $215 |
| Coopervision Inc. | 3 | $190 |
| Lumenis BE Inc | 1 | $149 |
| Sight Sciences, Inc. | 1 | $140 |
| Dompe US, Inc. | 1 | $125 |
| Glaukos Corporation | 2 | $117 |
| Alcon | 1 | $115 |
| Visioneering Technologies, Inc. | 1 | $93 |
| Sanofi | 1 | $77 |
| Aerie Pharmaceuticals, Inc. | 1 | $73 |
| Kala Pharmaceuticals, Inc. | 1 | $66 |
| ASD Specialty Healthcare, LLC | 1 | $62 |
| Maculogix, Inc. | 1 | $58 |
| Optos, Inc. | 3 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$250
- TEPEZZA$240
- XDEMVY$232
- optilight$149
- TEARCARE SYSTEM$140
- VYZULTA$125
- Oxervate$125
- DAILIES TOTAL1$115
- Precision 1$115
- TOTAL30$115
- INFUSE$113
- RESTASIS MULTIDOSE$109
- Prokera$107
How this compares
$2,967 in reported general payments places this provider in the 80th percentile of 20 low vision rehabilitation providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $755 |
| Latanoprost | 57 | $283 |
| Timolol Maleate | 12 | $133 |
Paid to pharmacies, not to this prescriber.
Other low vision rehabilitation in New Hyde Park
- Todd PunimMonroe$4K
- Kristin ProtosowRonkonkoma$4K
- Tracy SheedyRed Hook$3K
- Jeffrey CalhounWilliamsville$3K
- John RundquistAmherst$2K
- Charles HollanderNew York$2K
- Emily ChuForest Hills$814
- Robert ChunNew York$448
- Carolyn IhrigFredonia$368
- Shandor ZelengerNew York$263
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.